| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.092 | 0.6 |